Company CVAbout Phaarmasia Ltd 
Phaarmasia Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai. M/s Phaarmasia Limited Unit-II was established in 1993-94. The Company is engaged in manufacturing and marketing of Oral contraceptive tablets" with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports.
Company Coordinates
Company Details
16 Phase III, I D A Jeedimetla Hyderabad Telangana : 500055
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
No Details Available.
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Maneesh Pharmaceuticals Limited (44.22%)
Highest Public shareholder
Kaushik L M (1.89%)
Individual Investors Holdings
25.82%
Board of Directors
Management
Designation
Remuneration
Vinay Ramakant Sapte
Director
1.1 lacs
Maneesh R Sapte
Non Executive Director
0
Y N Bhaskara Rao
Whole-time Director
29.05 lacs
Rashmi V Sapte
Director
80.0 k
PRAVIN M. HEGDE
Independent Director
0
Ajit G Jamkhandikar
Independent Director
0
Urvashi Bhatia
Company Sec. & Compli. Officer
3.27 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Cost of Material Consumed
18.3753
0%
Cost of Material Consumed
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Tablets
15.32
71.56%
Processing Conversion Charges & Others
5.39
25.20%
Pastes, Creams & Ointments
0.64
2.97%
Tablets
Tablets
Processing Conversion Charges & Others
Processing Conversion Charges & Others
Pastes, Creams & Ointments
Pastes, Creams & Ointments
Stock DNARevenue and Profits:
Net Sales:
17 Cr
(Quarterly Results - Sep 2025)
Net Profit:
2 Cr
Pharmaceuticals & Biotechnology
INR 55 Cr (Micro Cap)
67.00
34
0.00%
-0.04
7.26%
4.84
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
